LONZA GROUP AG Toevoegen aan een lijst
Financiële vergelijkingen Lonza Group AG
Aandelen
LONN
CH0013841017
Biotechnologie & Medisch Onderzoek
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 591,00 CHF | +1,34% |
|
+6,60% | +10,30% |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Omzet | Nettomarge | Ebit-marge | ROE | ROA | Leverage | |
|---|---|---|---|---|---|---|---|
| 7,98 mld. | 9.74% | 13.98% | 6.52x | 3.82x | 0.46x | ||
| 14,98 mld. | 9.06% | 20.36% | 32.01x | 5.22x | 3.45x | ||
| 1,68 mld. | 24.61% | 29.93% | 5.07x | 4.31x | 1.46x | ||
| 2,33 mld. | 42.31% | 50.91% | 18.27x | 14.91x | -1.85x | ||
| 8,12 mld. | 7.54% | 19.31% | 6.9x | 3.58x | 2x | ||
| 6,85 mld. | 68.84% | 61.90% | -28.59x | -21.29x | 2.38x | ||
| 1,16 mld. | 14.50% | 31.94% | 14.11x | 6.29x | 0.4x | ||
| 1,89 mld. | 15.00% | 17.94% | 59.83x | 18.8x | -0.29x | ||
| 1,97 mld. | 17.37% | 26.90% | 4.69x | 2.75x | 0.69x | ||
| 4,13 mld. | 11.49% | 20.31% | 16.7x | 6.95x | 2.34x | ||
| 532 mln. | 40.26% | - | - | - | - | ||
| 11,58 mln. | 3,768.28% | 4,207.12% | -34.76x | -30.38x | 3.85x | ||
| 249 mln. | 203.30% | 194.99% | -157.13x | - | 0.99x | ||
| 343 mln. | 1.04% | 10.29% | 34.35x | 12.03x | -1.95x | ||
| 1,63 mld. | 13.88% | 14.92% | 13.86x | 6.82x | 1.36x | ||
| 788 mln. | 46.45% | 44.80% | -76.34x | -13.26x | 3.21x | ||
| 1,04 mld. | 27.44% | 35.35% | 9.95x | 7.09x | -1.51x | ||
| 1,66 mld. | 21.39% | 24.90% | 21.69x | 11.88x | -1.07x | ||
| 686 mln. | 19.38% | 22.41% | 9x | - | -1.79x | ||
| Gemiddelde | 3,05 mld. | percentage-no-prefix | percentage-no-prefix | -2,44x | 2,47x | 0,79x | |
| Gewogen gemiddelde per kap. | 5,4 mld. | percentage-no-prefix | percentage-no-prefix | 5,02x | 3,06x | 1,15x |
- Beurs
- Aandelen
- Koers LONN
- Sector Lonza Group AG
- Financiële vergelijkingen
